期刊文献+

布地奈德气雾剂治疗支气管哮喘的疗效观察 被引量:4

EFFECTS OF INHALED BUDESONIDE ON ASTHMA
下载PDF
导出
摘要 布地奈德(Budesonide)是一种非卤代化糖皮质激素,具有比其他同类药物更强的局部抗炎作用。本研究采用随机双盲、空白对照方法,74例轻、中度哮喘病人中,36例用布地奈德气雾剂治疗,38例用空白对照气雾剂。经4周治疗,结果显示,治疗组在肺功能提高(FEV1,FEV1%,P值)曹均小于0.001)、减少合用β2激动剂(P<0.01)以及症状体征改善方面均优于对照组,副作用与对照组无差异。说明布地奈德气雾剂治疗支气管哮喘具有较高的有效性和安全性。 udesonide is one of preparations of non- halogenated glucocorticosteroid which has beenshown to have greater local antiinflammatory activity. Seventy-two patients with slight or moder-ate asthma were studied with random,double- blind and placebocontrolled design. Thirty- six pa-tients were treated with inhaled budesonkde and 38 with placebo, After four weeks,the treatedgroup had a significant improvement of symptoms,lung function(FEV1,FEV1 %,P<0.001)andβ2-agonist usage was reduced(P<0.018 ).There was no different with regard to the side effectbetvVeen the two groups.
出处 《南京铁道医学院学报》 1995年第3期175-177,共3页 Journal of Nanjing Railway Medical College
关键词 布地奈德 气雾剂 哮喘 budesonide inhalation asthma
  • 相关文献

同被引文献16

  • 1刘春涛.哮喘管理和预防袖珍指南(2006年修订版)——根据哮喘管理和预防的全球策略[J].中国呼吸与危重监护杂志,2007,6(2):148-158. 被引量:20
  • 2谢宝辉,邓新宇,焦维克.普米克都保治疗38例轻度支气管哮喘疗效观察[J].福建医药杂志,2007,29(1):141-141. 被引量:2
  • 3阿斯特拉(无锡制药有限公司).布地奈德(丁地去炎松)Budesonide[J].新医学,1997,28(1):36-36.
  • 4Masoli M, Fabian D, Holt S, et al. The global burden of asthma : executive summary of the GINA Dissemination Committee report. Allegy,2004 ,59 :469-478.
  • 5Pearlman D. S, Berger WE, Kerwin E, et al. Once-daily ciclesonide improves lung function and is well tolerated by patients with,mild-to-moderate persistent asthma. J Allergy Clin Immunol, 2005,116(6) :1206.
  • 6Langdon C. G, Adler M, Mehra S, et al. Once-daily cielesonide 80 or 320 microg for 12 weeks is safe and effective in patients with persistent asthma. Respir Med,2005,99(10) :1275-1285.
  • 7Chapman K. R, Patel P, D Urzo AD, et ah Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma. Allergy,2005,60( 3 ) :330-337.
  • 8Baumgartner R. A, Martinez G, Edelman JM, et al. Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone. Eur Respir J,2003,21 ( 1 ) :123-128.
  • 9Yurdakul A. S, Taci N, Eren A, et al. Comparative efficacy of oncedaily therapy with inhaled corticosteroid, leukotriene antagonist or sustained-release theophylline in patients with mild persistent asthma. Respir Med ,2003,97 ( 12 ) : 1313-1319.
  • 10Riccioni G, Vecchia RD, D' Orazio N, et al. Comparison of montelukast and budesonide on bronchial reactivity in subjects with mild-moderate persistent asthma. Pulm Pharmacol Ther, 2003,16 ( 2 ) : 111-114.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部